| scholarly article | Q13442814 |
| P50 | author | Douglas F. Nixon | Q44059330 |
| P2093 | author name string | Becky Schweighardt | |
| Duncan A Meiklejohn | |||
| Jonas J Heymann | |||
| Walter J Moretto | |||
| Edward J Grace | |||
| Ann-Marie Roy | |||
| P2860 | cites work | Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 |
| HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease | Q24524292 | ||
| The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus | Q28259668 | ||
| The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates | Q28282895 | ||
| T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV | Q28646817 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene | Q29614892 | ||
| Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection | Q29614956 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
| HIV-1 infection in a man homozygous for CCR5▵32 | Q58277776 | ||
| HIV-1 infection in an individual homozygous for the CCR5 deletion allele | Q73122336 | ||
| HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group | Q73296691 | ||
| An HIV-1-infected individual homozygous for the CCR-5 delta32 allele and the SDF-1 3'A allele | Q77310387 | ||
| HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion | Q30233544 | ||
| Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue | Q33787161 | ||
| Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status | Q33854835 | ||
| Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells | Q33957148 | ||
| Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence | Q34342429 | ||
| CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue | Q34838416 | ||
| In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells | Q34977020 | ||
| CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques | Q35978751 | ||
| A novel strategy for constructing clustered point mutations | Q36135516 | ||
| HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells | Q36370102 | ||
| Change in coreceptor use correlates with disease progression in HIV-1--infected individuals | Q36376800 | ||
| HIV-1 selection by epidermal dendritic cells during transmission across human skin | Q36400855 | ||
| Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation | Q36783797 | ||
| Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates | Q36827410 | ||
| Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. | Q38890421 | ||
| Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells | Q38933102 | ||
| Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1. | Q38951830 | ||
| The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro. | Q38956174 | ||
| Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. | Q39031170 | ||
| Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation | Q39399217 | ||
| Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population | Q39439717 | ||
| Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread | Q39529308 | ||
| Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. | Q39551934 | ||
| Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage | Q39558640 | ||
| Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression | Q39604766 | ||
| Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution | Q40060900 | ||
| Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. | Q40061126 | ||
| Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex | Q40128160 | ||
| Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure | Q41212897 | ||
| Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. | Q41655443 | ||
| HIV-1 infection in a heterosexual man homozygous for CCR-5 delta32. | Q43988706 | ||
| Differential effects of CD28 costimulation on HIV production by CD4+ cells. | Q44253774 | ||
| Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection | Q45875120 | ||
| Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation | Q45877028 | ||
| Chemokine receptors: keys to AIDS pathogenesis? | Q47964346 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9164-9173 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1 | |
| P478 | volume | 78 |
| Q28728917 | A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro |
| Q22251080 | Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection |
| Q38630677 | Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1. |
| Q34267043 | Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences |
| Q92990096 | Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage |
| Q33459192 | Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection |
| Q28274045 | Dissecting How CD4 T Cells Are Lost During HIV Infection |
| Q57296858 | Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes |
| Q35693815 | Fluorescent Reporter Signals, EGFP, and DsRed, Encoded in HIV-1 Facilitate the Detection of Productively Infected Cells and Cell-Associated Viral Replication Levels. |
| Q35160655 | Human immunodeficiency virus persistence and production in T-cell development |
| Q35848314 | In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss |
| Q34846620 | Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. |
| Q37415416 | Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression. |
| Q36112824 | Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes. |
| Q36857108 | Role of Nef in HIV-1 replication and pathogenesis |
| Q92628205 | The Differential Anti-HIV Effect of a New Humic Substance-Derived Preparation in Diverse Cells of the Immune System |
Search more.